RxDoctor Payments Data

Sonya Norman, MD

Family Medicine · Brighton, CONPI 1245385202

Payments from drug & device makers

$933in general payments, 2019–2025

Across 22 payments — averaging $42.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$462
  • Johnson & Johnson$140
  • Rhythm Pharmaceuticals, Inc.$98
  • Exact Sciences$69
  • Astellas Pharma US Inc$40
  • Lilly USA, LLC$32
  • plus $91 from 5 others

What the payments were for

  • Food & beverage$933100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$933 in reported general payments places this provider in the 80th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$27,937
Medicare patients
137
Services billed
415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$54,754
MounjaroTirzepatide32$40,714
JardianceEmpagliflozin24$20,501
XareltoRivaroxaban19$19,345
TrulicityDulaglutide13$12,848
PremproEstrogen,con/M-Progest Acet12$2,753
Bupropion XlBupropion Hcl64$2,276
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,239
Levothyroxine Sodium201$1,710
Albuterol Sulfate HfaAlbuterol Sulfate40$1,539
Omeprazole96$1,391
Gabapentin74$1,302
Atorvastatin Calcium165$1,112
Lisinopril148$936
Duloxetine Hcl31$840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$462$54,75447 claims
Lilly USA, LLCMounjaro, Trulicity$32$53,56145 claims
Johnson & JohnsonXarelto$140$19,34519 claims
AbbVieSynthroid$20$80423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Brighton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →